Home/Medicines/Masitinib
All medicines

Masitinib

Prescription
Tyrosine Kinase Inhibitor (Chemotherapy)
Last reviewed 21 Apr 2026 · PetCare.AI Editorial Team
Species
Dog, Cat
Brands
2 available
Interactions
1 documented
Formulations
1

Mechanism of action

Selectively inhibits c-Kit (CD117) tyrosine kinase, blocking stem cell factor (SCF)-dependent signaling involved in mast cell tumor growth, survival, and differentiation. Also inhibits PDGFR and FAK.

At a glance

Class
Tyrosine Kinase Inhibitor (Chemotherapy)
Schedule
Prescription (Chemotherapy)
Storage
Store at room temperature below 30°C

Dosing

🐕

Dog

FDA-approved for Grade 2–3 recurrent/non-resectable canine mast cell tumors with
Dose
12.5 mg/kg
Route
PO
Frequency
q24h
🐈

Cat

Not approved in cats; limited veterinary oncology data
Dose
—
Route
PO
Frequency
N/A

Formulations

💊

Other — 1

Strength
—

Storage

Store at room temperature below 30°C

Safety

Monitoring parameters

CBC q2 weeks for first 3 months, then monthlyBiochemistry panel (hepatic, renal)Body weightAlbumin levels

Interactions

Moderate — 1

Meloxicam
moderate
Both can cause GI ulceration independently (masitinib: GI toxicity from c-Kit inhibition; meloxicam: prostaglandin inhibition). Combined GI toxicity risk.
Management: Monitor GI signs closely. Use gastroprotectant (omeprazole). Some oncologists avoid concurrent NSAIDs with TKIs.

Brands

Other markets

Masivet
Kinavet

FAQs

Frequently asked questions

›What is Masitinib?
Masitinib is a tyrosine kinase inhibitor (chemotherapy) used in pets. Selectively inhibits c-Kit (CD117) tyrosine kinase, blocking stem cell factor (SCF)-dependent signaling involved in mast cell tumor growth, survival, and differentiation. Also inhibits PDGFR and FAK.
›What is Masitinib used for in pets?
Masitinib is used in veterinary medicine for: FDA-approved for Grade 2–3 recurrent/non-resectable canine mast cell tumors with; Not approved in cats; limited veterinary oncology data.
›What is the Masitinib dose for dogs?
For dogs, Masitinib is typically dosed as follows — FDA-approved for Grade 2–3 recurrent/non-resectable canine mast cell tumors with: 12.5 mg/kg PO q24h. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›What is the Masitinib dose for cats?
For cats, Masitinib is typically dosed as follows — Not approved in cats; limited veterinary oncology data: undefined undefined PO N/A. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›Does Masitinib need a prescription?
Yes. Masitinib is a prescription medication and should only be administered under veterinary supervision.

References

References

Textbooks & handbooks

  • Plumb, D.C. Plumb's Veterinary Drug Handbook. 10th ed., Wiley-Blackwell, 2023.
  • Vail, D.M., Thamm, D.H., & Liptak, J.M. (eds.). Withrow & MacEwen's Small Animal Clinical Oncology. 6th ed., Saunders/Elsevier, 2020.
  • Riviere, J.E., & Papich, M.G. (eds.). Veterinary Pharmacology and Therapeutics. 10th ed., Wiley-Blackwell, 2018.
  • National Research Council. Nutrient Requirements of Dogs and Cats. National Academies Press, Washington DC, 2006.
  • The Merck Veterinary Manual. Merck & Co., Online edition. https://www.merckvetmanual.com/

Clinical guidelines & consensus

  • Fletcher, D.J., Boller, M., Brainard, B.M., et al. "RECOVER Evidence and Knowledge Gap Analysis on Veterinary CPR." Journal of Veterinary Emergency and Critical Care, 2012;22(S1):S102–S131.
  • American Animal Hospital Association. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. AAHA Press.

Journals & peer-reviewed studies

  • Hogan, D.F., Fox, P.R., Jacob, K., et al. "Secondary prevention of cardiogenic arterial thromboembolism in the cat: The FAT CAT study." Journal of Veterinary Cardiology, 2015;17(Suppl 1):S306–S317.
  • Boswood, A., Häggström, J., Gordon, S.G., et al. "Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study — A Randomized Clinical Trial." Journal of Veterinary Internal Medicine, 2016;30(6):1765–1779.
  • ASPCA Animal Poison Control Center. Toxicology and Poison Management Guidelines. American Society for the Prevention of Cruelty to Animals. https://www.aspca.org/pet-care/animal-poison-control

Regulatory & approvals

  • Central Drugs Standard Control Organisation (CDSCO), Government of India. Veterinary Drug Approval Registry, 1969–2026. Directorate General of Health Services. https://cdsco.gov.in/

Databases

  • Washington State University, College of Veterinary Medicine. Veterinary Clinical Pharmacology Laboratory (VCPL) — MDR1 Multidrug Sensitivity Database. https://vcpl.vetmed.wsu.edu/
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet. Find a vet near you →

Related medicines

Other medicines in the same class (Tyrosine Kinase Inhibitor).

Toceranib Phosphate
Rx
Inhibits multiple receptor tyrosine kinases including KIT, VEGFR, and PDGFR, blocking tumor cell proliferation and angiogenesis
dog